Startseite Kongressberichte 2020 ASCO20 Virtual Scientific Meeting Oral Sessions Gynecologic Cancer

Gynecologic Cancer

Oncoletter provides you with the abstract's links. To see more, go the ASCO Meeting Library while clicking on the link of the study-titles (to see videos and slides needs a payable registration)

Clinical trial information: NCT01166737
 
————————————————————————————————————————————————————————
 
6001 A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.
 
Rongyu Zang, Jianqing Zhu, Tingyan Shi, et al.
 
 
————————————————————————————————————————————————————————
 
6002 Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.
 
Andres Poveda, Anne Floquet, Jonathan A. Ledermann, et al.
 
Clinical trial information: NCT01874353
 
 
CCO Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting:
————————————————————————————————————————————————————————
 
6003 A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.
 
Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis, et al.
 
Clinical trial information: NCT02446600
————————————————————————————————————————————————————————
 
6004 Mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients (pts) with platinum-agnostic ovarian cancer.
 
Lucy Gilbert, Ana Oaknin, Ursula A. Matulonis, et al.
 
Clinical trial information: NCT02606305
————————————————————————————————————————————————————————
 
6005 Final results from the KEYNOTE-100 trial of pembrolizumab in patients with advanced recurrent ovarian cancer.
 
Ursula A. Matulonis, Roni Shapira, Alessandro Santin, et al. 
 
Clinical trial information: NCT02674061
————————————————————————————————————————————————————————
 
6006 Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer.
 
Vincent Balaya, Benedetta Guani, Laurent Magaud, et al.
 
 
————————————————————————————————————————————————————————
 
6007 Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.
 
He Huang, Yanling Feng, Ting Wan, Yanna Zhang, et al.
 
Clinical trial information: NCT00806117
————————————————————————————————————————————————————————
 
LBA6008 Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A.
 
Benoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, Jet al.
 
Clinical trial information: NCT03135769.
 
————————————————————————————————————————————————————————
 
Kedar Kirtane, Erminia Massarelli, Glenn J. Hanna, et al.
 
The abstract concludes:
This study is currently open and accruing patients. Clinical trial information: NCT03912831.
————————————————————————————————————————————————————————
 

101 Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers.

Scott Norberg, Nisha Nagarsheth, Andrew Sinkoe, et al. 

Clinical trial information: NCT02858310

————————————————————————————————————————————————————————————————————————————
 
MORE ABSTRACTS:
 
Clinical Science Symposium
Learning from the Biology: Advances in Endometrial and Ovarian Cancer
Poster Discussion Session
Gynecologic Cancer
 
Poster Session
Gynecologic Cancer
 
ASCO Direct™ Focus – ASCO®20 Virtual Program  
Top presentations and expert interviews now available on demand!
Visit ascodirect2020.com and enter the following username „asco“ and password: „oncology"  
ASCO Direct Focus is an officially licensed online program for oncology professionals worldwide, providing complimentary access to an ASCO-curated selection of top presentations from the ASCO20 Virtual Scientific Program, plus expert commentaries.
Gynecologic (Abstracts #6001, 6005, LBA6008)
Access Content Now